UK pharmacy and clinical practice, guided by the Specialist Pharmacy Service (SPS), generally discourages the routine use of multi-dose vials and requires that any in-use shelf life and storage conditions follow validated, product-specific data
Noveltreat will be available in five dose strengths 0.25 mg/0.5mL, 0.5 mg/0.5 mL, 1 mg/0.5 mL, 1.7 mg/0.75 mL, and 2.4 mg/0.75 mL, with a maintenance dose of 2.4 mg once weekly
Americans and most Europeans, however, face a long wait: patent-term extensions and other protections in those regions mean true generics for Ozempic and Wegovy likely won't arrive until the early 2030s, a delay critics say will cost patients and taxpayers tens of billions of dollars
Are you comfortable with self-injection
The scientists tracked hypotensive events over 6, 12 and 24 months after patients started GLP-1 therapy and compared them with rates before GLP-1 initiation
Retatrutide includes GLP-1 activity, but it is not only a GLP-1 drug